Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David H. Harpole, MD
Duke Cancer Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
94 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Vincent'S Hospital - Melbourne
Fitzroy, Victoria, Australia
- Regional Medical Center
Anniston, Alabama, United States
- Uab Comprehensive Cancer Center
Birmingham, Alabama, United States
- Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
Burbank, California, United States
- Glendale Memorial Hospital Comprehensive Cancer Center
Glendale, California, United States
- Rebecca and John Moores Ucsd Cancer Center
La Jolla, California, United States
- Facility name not stated
Pismo Beach, California, United States
- Robert and Beverly Lewis Family Cancer Care Center at Pomona Valley Hospital Medical Center
Pomona, California, United States
- Helen and Harry Gray Cancer Center at Hartford Hospital
Hartford, Connecticut, United States
- Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital
Fort Lauderdale, Florida, United States
- Memorial Cancer Institute at Memorial Regional Hospital
Hollywood, Florida, United States
- Ella Milbank Foshay Cancer Center at Jupiter Medical Center
Jupiter, Florida, United States
- Ccop - Mount Sinai Medical Center
Miami Beach, Florida, United States
- Nancy N. and J. C. Lewis Cancer and Research Pavilion at St. Joseph'S/candler
Savannah, Georgia, United States
- Resurrection Medical Center
Chicago, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Elkhart Clinic, Llc
Elkhart, Indiana, United States
- Elkhart General Hospital
Elkhart, Indiana, United States
- Michiana Hematology-Oncology, Pc - Elkhart
Elkhart, Indiana, United States
- Howard Community Hospital
Kokomo, Indiana, United States
- Center for Cancer Therapy at Laporte Hospital and Health Services
La Porte, Indiana, United States
- Michiana Hematology-Oncology, Pc - South Bend
Mishawaka, Indiana, United States
- Saint Joseph Regional Medical Center
Mishawaka, Indiana, United States
- Michiana Hematology Oncology Pc - Plymouth
Plymouth, Indiana, United States
- Ccop - Northern Indiana Cr Consortium
South Bend, Indiana, United States
- Memorial Hospital of South Bend
South Bend, Indiana, United States
- Michiana Hematology Oncology Pc - la Porte
Westville, Indiana, United States
- Cedar Rapids Oncology Associates
Cedar Rapids, Iowa, United States
- Mercy Regional Cancer Center at Mercy Medical Center
Cedar Rapids, Iowa, United States
- Central Baptist Hospital
Lexington, Kentucky, United States
- Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky, United States
- Mary Bird Perkins Cancer Center - Baton Rouge
Baton Rouge, Louisiana, United States
- Maine Center for Cancer Medicine and Blood Disorders - Scarborough
Scarborough, Maine, United States
- Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
Baltimore, Maryland, United States
- Greater Baltimore Medical Center Cancer Center
Baltimore, Maryland, United States
- Cancer Institute at St. Joseph Medical Center
Towson, Maryland, United States
- Dana-Farber/brigham and Women'S Cancer Center
Boston, Massachusetts, United States
- Dana-Farber/harvard Cancer Center at Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Newton-Wellesley Hospital
Newton, Massachusetts, United States
- Green Bay Oncology, Limited - Escanaba
Escanaba, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2009
- Primary completion
- 30 Nov 2011
- Completion
- 30 Nov 2012
- Last update posted
- 27 Mar 2017
- Registered enrollment
- 34
- Registry id
- NCT00863512
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.